Moving towards focused growth and value creation

At Balaxi, we are a branded IPR-based pharmaceutical company focusing on frontier markets, with vast and growing portfolio od drugs across multiple therapeutic segments. We aim to be amongst the leading pharmaceutical players in multiple markets that offer us scale, market homogeneity, healthy margins, and quality growth where value and volume are both established in a balanced way. While we are focusing on establishing strong portfolios of pharmaceutical formulations, we are also building a branded consumer products business, which complements our pharma business.

Over the years, through our consistent growth, we have demonstrated that attractive returns can be achieved by investing in proprietary and methodical market research, intellectual property, meticulous planning, and flawless execution of logistics. Therefore, every day, we focus on investing in robust processes, time-tested systems, and prudent strategies to ensure a lucrative performance. At operational levels, we outsource our production requirements to cost-beneficial contract manufacturing facilities that are based out of India, China, and Europe. This allows us to allocate and utilise our capital prudently, thereby optimising the speed-to-market for our new products in existing and new geographies. Given the variety of products we produce, this approach facilitates Balaxi to channel its resources and energy on other value chain stages to augment significant returns.

Our smooth business operations and implementation of strategies are made possible due to our highly qualified and capable human capital. Our employees are Balaxi’s most valued asset. We continuously invest in their development to ensure that they are not only at the forefront of catering to our client needs but also capable of adapting to the changing business environment. In addition to this, we encourage continuous learning and collaborative work culture, which helps our people to deliver effortlessly and keeps them motivated under every situation.

As we move forward to achieve consistent growth and deliver uninterrupted value to our stakeholders, we are proud and confident of our systems and processes that allow us to explore new opportunities and expand our reach. With every passing day, we are inching one step closer to emerge as the pharmaceutical giant while staying intact on our purpose to bring high-quality medicines within the reach of populations in promising frontier markets. 

Ashish Maheshwari

Chairman & Managing Director